Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in October2008
*Drugs may be covered by multiple patents
Tradename
Applicant
Generic Name
Patent Number
Patent Expiration
CASODEX
Astrazeneca
bicalutamide
4,636,505
Oct 1, 2008
CONDYLOX
Watson Pharms
podofilox
5,057,616
Oct 15, 2008
COSOPT
Merck
dorzolamide hydrochloride; timolol maleate
4,797,413
Oct 28, 2008
ELIGARD
Qlt Usa
leuprolide acetate
4,938,763
Oct 3, 2008
ELIGARD
Qlt Usa
leuprolide acetate
5,733,950
Oct 3, 2008
ELIGARD
Qlt Usa
leuprolide acetate
5,739,176
Oct 3, 2008
ELIGARD
Qlt Usa
leuprolide acetate
RE37950
Oct 3, 2008
FERIDEX I.V.
Amag Pharms Inc
ferumoxides
5,055,288
Oct 8, 2008
GASTROMARK
Amag Pharms Inc
ferumoxsil
5,055,288
Oct 8, 2008
IONSYS
Alza
fentanyl hydrochloride
5,232,438
Oct 3, 2008
MIRCETTE
Duramed
desogestrel; ethinyl [...]
A lot of people have been asking my opinion on when a concise generic biologic regulatory pathway will emerge in the United States, and I give them all the same answer: Later.
In my opinion complex regulatory schemes are not areas in which the United States can effectively lead. Why not? Because the size of the [...]
I recently had the opportunity to conduct a brief interview with Mireille Gingras, Ph.D. President and CEO of HUYA Bioscience on doing business with and in China:
Tell me about HUYA and what makes the company unique?
HUYA Bioscience International has pioneered the most innovative and productive approach for pharmaceutical co-development between the U.S. and China. [...]
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in September 2008
*Drugs may be covered by multiple patents
Tradename
Applicant
Generic Name
Patent Number
Patent Expiration
ANDRODERM
Watson Labs
testosterone
4,855,294
Sep 6, 2008
AVITA
Mylan Bertek
tretinoin
5,045,317
Sep 3, 2008
DDAVP
Sanofi Aventis Us
desmopressin acetate
5,047,398
Sep 10, 2008
OPANA ER
Endo Pharms
oxymorphone hydrochloride
5,128,143
Sep 19, 2008
RESCULA
R Tech Ueno Ltd
unoprostone isopropyl
5,001,153
Sep 19, 2008
Courtesy of DrugPatentWatch.com
Guest content from Turner Investment Partners‘ Heather Flick McMeekin, Frank Sustersic, Vijay Shankaran, and Theresa Hoang:
Contract research helps keep drug pipeline flowing
Imagine a new-product development process that typically lasts 10 to 15 years, has only a one in 5,000 chance of succeeding, and costs at least $800 million. That’s the daunting reality that biopharmaceutical companies [...]
460 pages
Hardcover:978-09734676-5-9
Hardcover:978-09734676-6-6
Third Edition
August, 2008
Homepage
Building Biotechnology
Business, Regulations, Patents, Law, Politics, Science
The definitive primer and leading textbook on the business of biotechnology is now available in its third edition. This new edition is over 100 pages longer than the second edition and adds new chapters, new figures and tables, and additional case examples.
Building Biotechnology [...]